Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Change in Taxes (2016 - 2020)

Historic Change in Taxes for Ernexa Therapeutics (ERNA) over the last 11 years, with Q4 2020 value amounting to $21000.0.

  • Ernexa Therapeutics' Change in Taxes rose 80000.0% to $21000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $39000.0, marking a year-over-year increase of 380000.0%. This contributed to the annual value of $5000.0 for FY2020, which is 40000.0% up from last year.
  • As of Q4 2020, Ernexa Therapeutics' Change in Taxes stood at $21000.0, which was up 80000.0% from $7000.0 recorded in Q1 2020.
  • Ernexa Therapeutics' 5-year Change in Taxes high stood at $21000.0 for Q4 2020, and its period low was -$34000.0 during Q4 2018.
  • Over the past 5 years, Ernexa Therapeutics' median Change in Taxes value was $7000.0 (recorded in 2018), while the average stood at $500.0.
  • In the last 5 years, Ernexa Therapeutics' Change in Taxes crashed by 210000.0% in 2017 and then skyrocketed by 80000.0% in 2020.
  • Over the past 5 years, Ernexa Therapeutics' Change in Taxes (Quarter) stood at -$7000.0 in 2016, then skyrocketed by 257.14% to $11000.0 in 2017, then plummeted by 409.09% to -$34000.0 in 2018, then soared by 91.18% to -$3000.0 in 2019, then soared by 800.0% to $21000.0 in 2020.
  • Its Change in Taxes stands at $21000.0 for Q4 2020, versus $7000.0 for Q1 2020 and -$3000.0 for Q4 2019.